As autophagy generally plays a protective role in cancer therapy, and both PFKFB3 deprivation and membrane transporter/ion channel inhibitors attenuated the autophagic flux induced by DDP, thus, the blocking autophagic elimination of DDP was one of the reasons that resulted in the DDP resistance release. Here, PFKFB3 is linked to cancer.